M
Mauro Castellarin
Researcher at University of Pennsylvania
Publications - 20
Citations - 2703
Mauro Castellarin is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Islet & Regulatory sequence. The author has an hindex of 16, co-authored 20 publications receiving 2246 citations. Previous affiliations of Mauro Castellarin include BC Cancer Agency & McGill University Health Centre.
Papers
More filters
Journal ArticleDOI
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Mauro Castellarin,René L. Warren,J. Douglas Freeman,Lisa Dreolini,Martin Krzywinski,Jaclyn Strauss,Rebecca O Barnes,Peter H. Watson,Emma Allen-Vercoe,Richard A. Moore,Robert A. Holt +10 more
TL;DR: Overabundance of Fusobacterium sequences in tumor versus matched normal control tissue is verified by quantitative PCR analysis from a total of 99 subjects, and a positive association with lymph node metastasis is observed.
Journal ArticleDOI
Derivation of HLA types from shotgun sequence datasets
René L. Warren,Gina Choe,Douglas J Freeman,Mauro Castellarin,Sarah Munro,Richard A. Moore,Robert A. Holt,Robert A. Holt +7 more
TL;DR: HLAminer, a computational method for identifying HLA alleles directly from shotgun sequence datasets that circumvents the additional time and cost of generating HLA-specific data and capitalizes on the increasing accessibility and affordability of massively parallel sequencing.
Journal ArticleDOI
Sequence analysis of T-cell repertoires in health and disease
Daniel J Woodsworth,Daniel J Woodsworth,Mauro Castellarin,Mauro Castellarin,Robert A. Holt,Robert A. Holt,Robert A. Holt +6 more
TL;DR: T-cell antigen receptor (TCR) variability enables the cellular immune system to discriminate between self and non-self as mentioned in this paper, and T-cell repertoire sequencing is still in its infancy, however, it is expected that maturation of the field will involve the introduction of improved, standardized tools for data handling, deposition and statistical analysis, as well as the emergence of new and equivalently large-scale technologies for Tcell functional analysis and antigen discovery.
Journal ArticleDOI
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Darin A. Wick,John R. Webb,Julie S. Nielsen,Spencer D. Martin,David R. Kroeger,Katy Milne,Mauro Castellarin,Kwame Twumasi-Boateng,Peter H. Watson,Robert A. Holt,Brad H. Nelson +10 more
TL;DR: The findings reveal the limitations of spontaneous tumor immunity in the setting of standard treatments and suggest a high degree of ignorance of tumor mutations that could potentially be reversed by immunotherapy.
Sequence analysis of T-cell repertoires in health
TL;DR: This nascent field and TCR-seq methodology, which involves the use of next generation sequencing platforms to generate large numbers of short DNA sequences covering key regions of the TCR coding sequence, is introduced and discusses recent insights into healthy and diseased TCR repertoires.